Literature DB >> 31512117

Asthma, asthma control and risk of acute myocardial infarction: HUNT study.

Aivaras Cepelis1, Ben M Brumpton2,3,4, Lars E Laugsand5, Håvard Dalen6,7,8, Arnulf Langhammer9, Imre Janszky9,10, Linn B Strand9.   

Abstract

Asthma, a chronic inflammatory airway disease, shares several common pathophysiological mechanisms with acute myocardial infarction (AMI). Our aim was to assess the prospective associations between asthma, levels of asthma control and risk of AMI. We followed 57,104 adults without previous history of AMI at baseline from Nord-Trøndelag health study (HUNT) in Norway. Self-reported asthma was categorised as active asthma (i.e., using asthma medication) and non-active asthma (i.e., not using asthma medication). Levels of asthma control were defined as controlled, partly controlled, and uncontrolled based on the Global Initiative for Asthma guidelines. AMI was ascertained by linking HUNT data with hospital records. A total of 2868 AMI events (5.0%) occurred during a mean (SD) follow-up of 17.2 (5.4) years. Adults with active asthma had an estimated 29% higher risk of developing AMI [adjusted hazard ratio (HR) 1.29, 95% CI 1.08-1.54] compared with adults without asthma. There was a significant dose-response association between asthma control and AMI risk, with highest risk in adults with uncontrolled asthma (adjusted HR 1.73, 95% CI 1.13-2.66) compared to adults with controlled asthma (p for trend < 0.05). The associations were not explained by smoking status, physical activity and C-reactive protein levels. Our study suggests that active asthma and poor asthma control are associated with moderately increased risk of AMI. Further studies are needed to evaluate causal relationship and the underlying mechanisms and to clarify the role of asthma medications in the risk of AMI.

Entities:  

Keywords:  Asthma; Asthma control; Cardiovascular disease; Heart attack; Myocardial infarction

Mesh:

Year:  2019        PMID: 31512117     DOI: 10.1007/s10654-019-00562-x

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  36 in total

1.  Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis.

Authors:  Shelley R Salpeter; Thomas M Ormiston; Edwin E Salpeter
Journal:  Chest       Date:  2004-06       Impact factor: 9.410

2.  Cohort Profile: the HUNT Study, Norway.

Authors:  S Krokstad; A Langhammer; K Hveem; T L Holmen; K Midthjell; T R Stene; G Bratberg; J Heggland; J Holmen
Journal:  Int J Epidemiol       Date:  2012-08-09       Impact factor: 7.196

3.  Characteristics and Prognosis of Never-Smokers and Smokers with Asthma in the Copenhagen General Population Study. A Prospective Cohort Study.

Authors:  Yunus Çolak; Shoaib Afzal; Børge G Nordestgaard; Peter Lange
Journal:  Am J Respir Crit Care Med       Date:  2015-07-15       Impact factor: 21.405

4.  Increasing prevalence of asthma, allergic rhinoconjunctivitis and eczema among schoolchildren: three surveys during the period 1985-2008.

Authors:  Tonje Elisabeth Hansen; Bjørg Evjenth; Jan Holt
Journal:  Acta Paediatr       Date:  2012-11-01       Impact factor: 2.299

5.  Evaluation of inflammatory markers interleukin-6 (IL-6) and matrix metalloproteinase-9 (MMP-9) in asthma.

Authors:  Srilata Puru Naik; Mahesh P A; Jayaraj B S; SubbaRao V Madhunapantula; Sarah Raeiszadeh Jahromi; Manish Kumar Yadav
Journal:  J Asthma       Date:  2016-10-26       Impact factor: 2.515

6.  Inhaled corticosteroid use in asthma and the prevention of myocardial infarction.

Authors:  Samy Suissa; Themistocles Assimes; Paul Brassard; Pierre Ernst
Journal:  Am J Med       Date:  2003-10-01       Impact factor: 4.965

7.  Associations of Asthma and Asthma Control With Atrial Fibrillation Risk: Results From the Nord-Trøndelag Health Study (HUNT).

Authors:  Aivaras Cepelis; Ben M Brumpton; Vegard Malmo; Lars E Laugsand; Jan Pål Loennechen; Hanne Ellekjær; Arnulf Langhammer; Imre Janszky; Linn B Strand
Journal:  JAMA Cardiol       Date:  2018-08-01       Impact factor: 14.676

8.  Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial.

Authors:  Claes Held; Harvey D White; Ralph A H Stewart; Andrzej Budaj; Christopher P Cannon; Judith S Hochman; Wolfgang Koenig; Agneta Siegbahn; Philippe Gabriel Steg; Joseph Soffer; W Douglas Weaver; Ollie Östlund; Lars Wallentin
Journal:  J Am Heart Assoc       Date:  2017-10-24       Impact factor: 5.501

Review 9.  Chronic inflammation and asthma.

Authors:  Jenna R Murdoch; Clare M Lloyd
Journal:  Mutat Res       Date:  2009-09-19       Impact factor: 2.433

10.  Cardiovascular morbidity and the use of inhaled bronchodilators.

Authors:  Christine Macie; Kate Wooldrage; Jure Manfreda; Nicholas Anthonisen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more
  7 in total

1.  Autoantibodies to IgE can induce the release of proinflammatory and vasoactive mediators from human cardiac mast cells.

Authors:  Remo Poto; Vincenzo Patella; Gjada Criscuolo; Gianni Marone; Enrico Coscioni; Gilda Varricchi
Journal:  Clin Exp Med       Date:  2022-07-25       Impact factor: 5.057

2.  Association of Circulating IgE and CML Levels with In-Stent Restenosis in Type 2 Diabetic Patients with Stable Coronary Artery Disease.

Authors:  Jingmeng Liu; Qiujing Chen; Lin Lu; Qi Jin; Yangyang Bao; Tianyou Ling; Changjian Lin; Fenghua Ding; Xiaoqun Wang; Weifeng Shen; Ying Shen; Yang Dai; Liqun Wu
Journal:  J Cardiovasc Dev Dis       Date:  2022-05-13

3.  Objectives, design and main findings until 2020 from the Rotterdam Study.

Authors:  M Arfan Ikram; Guy Brusselle; Mohsen Ghanbari; André Goedegebure; M Kamran Ikram; Maryam Kavousi; Brenda C T Kieboom; Caroline C W Klaver; Robert J de Knegt; Annemarie I Luik; Tamar E C Nijsten; Robin P Peeters; Frank J A van Rooij; Bruno H Stricker; André G Uitterlinden; Meike W Vernooij; Trudy Voortman
Journal:  Eur J Epidemiol       Date:  2020-05-04       Impact factor: 8.082

4.  Association Between Asthma and All-Cause Mortality and Cardiovascular Disease Morbidity and Mortality: A Meta-Analysis of Cohort Studies.

Authors:  Bin Zhang; Zhi-Fei Li; Zhuo-Yu An; Li Zhang; Jing-Yi Wang; Meng-Di Hao; Yi-Jing Jin; Dong Li; An-Jian Song; Qiang Ren; Wen-Biao Chen
Journal:  Front Cardiovasc Med       Date:  2022-03-17

5.  Meta-Analysis of the Association Between Asthma and the Risk of Stroke.

Authors:  Zheng-Hua Fang; Zhi-Fei Li; Zhuo-Yu An; Si-Cheng Huang; Meng-Di Hao; Wei-Xing Zhang
Journal:  Front Neurol       Date:  2022-06-24       Impact factor: 4.086

6.  Major cardiovascular events in patients with severe COPD with and without asthma: a nationwide cohort study.

Authors:  Barbara Bonnesen; Pradeesh Sivapalan; Anna Kjær Kristensen; Mats Christian Højbjerg Lassen; Kristoffer Grundtvig Skaarup; Ema Rastoder; Rikke Sørensen; Josefin Eklöf; Tor Biering-Sørensen; Jens-Ulrik Stæhr Jensen
Journal:  ERJ Open Res       Date:  2022-09-26

7.  The Effect of Cardiovascular Comorbidities on Women Compared to Men: Longitudinal Retrospective Analysis.

Authors:  Elma Dervic; Carola Deischinger; Nils Haug; Michael Leutner; Alexandra Kautzky-Willer; Peter Klimek
Journal:  JMIR Cardio       Date:  2021-10-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.